Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]

Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923. The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article. The authors apologize for these errors and advise they do not affect th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Capstick TGD, Hopkinson NS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/665a780def7f4f83a834cce2eb97a521
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:665a780def7f4f83a834cce2eb97a521
record_format dspace
spelling oai:doaj.org-article:665a780def7f4f83a834cce2eb97a5212021-11-30T18:50:37ZAdapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]1178-2005https://doaj.org/article/665a780def7f4f83a834cce2eb97a5212021-11-01T00:00:00Zhttps://www.dovepress.com/corrigendum-adapting-inhaled-medication-practice-in-copd-and-asthma-to-peer-reviewed-fulltext-article-COPDhttps://doaj.org/toc/1178-2005Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923. The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article. The authors apologize for these errors and advise they do not affect the results of the paper. Read the original articleCapstick TGDHopkinson NSDove Medical Pressarticleethicscorporate social responsibilitypublic healthDiseases of the respiratory systemRC705-779ENInternational Journal of COPD, Vol Volume 16, Pp 3239-3241 (2021)
institution DOAJ
collection DOAJ
language EN
topic ethics
corporate social responsibility
public health
Diseases of the respiratory system
RC705-779
spellingShingle ethics
corporate social responsibility
public health
Diseases of the respiratory system
RC705-779
Capstick TGD
Hopkinson NS
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
description Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923. The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article. The authors apologize for these errors and advise they do not affect the results of the paper. Read the original article
format article
author Capstick TGD
Hopkinson NS
author_facet Capstick TGD
Hopkinson NS
author_sort Capstick TGD
title Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
title_short Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
title_full Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
title_fullStr Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
title_full_unstemmed Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
title_sort adapting inhaled medication practice in copd and asthma to avoid funding the tobacco industry [corrigendum]
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/665a780def7f4f83a834cce2eb97a521
work_keys_str_mv AT capsticktgd adaptinginhaledmedicationpracticeincopdandasthmatoavoidfundingthetobaccoindustrycorrigendum
AT hopkinsonns adaptinginhaledmedicationpracticeincopdandasthmatoavoidfundingthetobaccoindustrycorrigendum
_version_ 1718406328013029376